A panelist discusses how the COAT trial demonstrated that twice-daily 0.09% cyclosporine improves multiple signs and symptoms of dry eye disease within 28 days, highlighting the value of early ...
A panelist discusses how recent insights into dry eye disease highlight the importance of targeting both inflammation and tear production—showcasing treatments like cyclosporine drops and varenicline ...
Aldeyra Therapeutics Inc. is making another run at U.S. FDA clearance for reproxalap in dry eye disease (DED) after nailing the primary endpoint in a phase III randomized, double-masked, ...
The Nebraska Department of Economic Development (DED) has released the 2026-2027 Qualified Action Plan (QAP) for the Business Innovation Act (BIA), outlining how the DED will allocate funds and ...
Missouri is poised to meet a changing economic development landscape, and state personnel are seeking the public's input on the best path forward. The Missouri Department of Economic Development (DED) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results